Director of Research
Dr. Susanne Talcott
- Postdoctoral Research Associate in Pharmaceutics, University of Florida, Pharmaceutics Department, Center for Food Drug Interactions and Education, 2004-2006.
- Ph.D., Nutritional Sciences, University of Florida, Gainesville, FL, 2004
- M.S., Nutritional Sciences, University of Bonn, Bonn, Germany, equivalent to a combined BS/MS program, 1998
As Director of Science Research for the Institute for Obesity Research and Program Evaluation, Dr. Susanne Talcott works with the Institute Director and staff to help plan and prepare budgets and proposals for basic and applied bench science and clinical studies. She has supervisory responsibilities of the Institute’s laboratories in scientific research (two molecular laboratories, one cell culture lab, and one food product development and sensory evaluation lab), as well as coordination of laboratory data collection and analysis. She assists in coordinating grant proposal writing activities and funded project activities, including report writing and manuscript preparation. Dr. Talcott is focusing on establishing efficacy, safety and dosing recommendations for plant-based bioactive compounds. She applies pharmacometric tools and disease specific biomarkers in studying the efficacy of specific fruit, vegetable, and whole grain bioactives in addressing co-morbidities of obesity, including cardiovascular disease, diabetes and cancer. Included are antioxidant endpoints as well as biomarkers for inflammation, vascular endothelial function, apoptosis, cell signaling, and translational regulation.
Dr. Susanne Talcott’s overall research objective is to assess bioactive compounds in fruits and vegetables, dietary supplements, antioxidant fruit juices and other foods, in their role in the prevention of chronic diseases and the protection of health in an integrative, translational research approach (bench to bedside). Dr. Talcott is also working in the improvement of quality and determination of health benefits of grapes and wine in collaboration with the Texas Wine and Grape Industry.
Millions of Americans consume plant based foods, including dietary supplements and functional foods with the hope of preventing or even treating chronic diseases. However, very little research investigating the efficacy of antioxidant foods has been performed. Hence, consumers as well as food industry, have very little to no guidance regarding efficacy and dosing recommendations for these products.
It is our goal to establish efficacy, safety and dosing recommendations for plant based bioactive compounds, using pharmacometric tools and disease specific biomarkers for cardiovascular disease, diabetes and cancer. Including antioxidant endpoints as well as biomarkers for inflammation, vascular endothelial function, apoptosis, cell signaling and translational regulation.